Astrin Biosciences announced it raised $22.9 Million in an initial filing from an offering of $22.9 Million

Company

Location

About

Astrin Biosciences is a cancer intelligence company built to push the boundaries of technology – accelerating early detection and advancing cancer care. Astrin’s breakthrough cancer tests analyze the early signals in over 8,000 proteins to reveal what most tests miss: the earliest molecular signals in cancer development. Astrin Biosciences was founded on a bold idea: that health decisions should be based not just on what’s happening inside the body, but on the reality of the person living in it. Our Mission us to lead in cancer intelligence and early detection.